Chemical industry – Page 97
-
Business
UK urged to clean up London air
Think tank says ‘invisible’ pollution is public health problem comparable to obesity and alcohol
-
Business
GSK secures $3.6bn HGS deal
GlaxoSmithKline is set to buy Human Genome Sciences for $3.6 billion
-
BusinessObesity drug approved in US
Qsymia from Vivus joins Belviq in a lucrative part of the pharma industry
-
Business
First HIV drug approved as prevention
Truvada tablets can reduce the risk of infection for an HIV-negative person
-
BusinessThe future of PVC production?
Commercial interest in a semi-continuous approach seems to be on the rise
-
Business
Drug spending to hit $1.2tn in 2016
Growth is expected to bottom out at 3–4% for 2012 and then rise to 5–7% for 2016
-
Business
GSK drug shines in HIV trial
HIV–Aids drug candidate dolutegravir outperformed Atripla tablets in Phase III
-
BusinessInterview: EMA head Guido Rasi
Guido Rasi, head of the European Medicines Agency, wants to see greater transparency in drug development
-
Business
Is Sanofi cutting jobs in France?
News outlets are reporting plans to cut 1000-2000 employees in France
-
Business
Brazil hits BASF with worker payout
BASF and Shell have been ordered to pay BRL1 billion (£300 million) to compensate employees for damage to their health
-
CareersSuccouring success
Sarah Houlton reports on BioCity Nottingham, a start-up incubator helping fledgling companies find their feet
-
Business
Bayer buys crop protection firm for $425m
Bayer has struck a deal to buy US pest control products firm AgraQuest
-
Business
BMS and AstraZeneca buy Amylin for $7bn
Two pharma giants have teamed up to buy US biotech Amylin, responsible for the Byetta and Bydureon anti-diabetes brands
-
Business$3bn GSK fine sets new industry record
The fine relates to off label marketing and is the largest payment of its kind ever made by a drug company
-
Business
Roche rapped for side-effect reporting failure
European medicines regulator names and shames Swiss giant for not disclosing 80,000 instances of potential adverse drug reactions
-
Business
Roche cuts 1000 jobs with US R&D site closure
Streamlining strategy will see oncology and virology research moved to Switzerland and Germany
-
Business
US GM labelling rule quashed
The rule would have authorised state governments to enforce GM labels on food products
-
BusinessIndustrial nitroglycerin made fast and safe
Continuous production with microreactors is not only safer but also ten times quicker
-
Business
Nasonex patent ruling goes against Merck & Co
The court ruled that the Merck patent was valid - but Apotex won’t infringe it with its product